Boehringer Ingelheim signs a license agreement with Evec Inc. for its fully-human antibody programme
- Details
- Category: Boehringer Ingelheim
![Boehringer Ingelheim Boehringer Ingelheim](http://www.worldpharmanews.com/images/stories/logo/boehringeringelheim.gif)
Roche invests 215 million Swiss francs in diagnostics facility at Penzberg
- Details
- Category: Roche
![Roche Roche](http://www.worldpharmanews.com/images/stories/logo/roche.gif)
Shire Limited has changed its name to Shire plc
- Details
- Category: Shire
![Shire plc Shire plc](http://www.worldpharmanews.com/images/stories/logo/shire.gif)
Bayer starts new research cooperation in Asia
- Details
- Category: Bayer
![The Bayer Group The Bayer Group](http://www.worldpharmanews.com/images/stories/logo/bayer.gif)
Data from one-year liraglutide phase 3 study published in The Lancet
- Details
- Category: Novo Nordisk
![Novo Nordisk Novo Nordisk](http://www.worldpharmanews.com/images/stories/logo/novonordisk_b.gif)
US Court Denies Teva's Motion For Summary Judgment In Pulmicort Respules Patent Litigation
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](http://www.worldpharmanews.com/images/stories/logo/astrazeneca_b.gif)
Nycomed optimises its European manufacturing network
- Details
- Category: Nycomed
![Nycomed Nycomed](http://www.worldpharmanews.com/images/stories/logo/nycomed.gif)
More Pharma News ...
- Pfizer Launches New Medicine Safety Website for Healthcare Professionals and Patients
- Novo Nordisk acquires intellectual property rights from Neose Technologies
- Bayer HealthCare acquires German DIREVO Biotech AG
- DHL COLDCHAIN offers fast, reliable and flexible solutions designed for the Life Science Industry
- Bayer Intensifies Research in Early Diagnosis of Alzheimer's Disease
- Pfizer Will Withdraw Global Marketing Applications for Dalbavancin to Conduct a New Trial
- New low-dose oral contraceptive YAZ® launched in Europe